89 related articles for article (PubMed ID: 23189835)
1. [HBV genotypes distribution and YMDD spontaneous mutation in Qingdao population].
Wang LL; Yu XJ; Dong QJ; Chen HB; Zhou JH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):250-2. PubMed ID: 23189835
[TBL] [Abstract][Full Text] [Related]
2. [Study on the relations between hepatitis B virus large surface protein (LHBs) and HBV YMDD mutation].
Wang LJ; Sun Y; Fu HP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):48-9. PubMed ID: 20848850
[TBL] [Abstract][Full Text] [Related]
3. HBV genotype C strains with spontaneous YMDD mutations may be a risk factor for hepatocellular carcinoma.
Yang J; Chen X; Zhang H; Chen G
J Med Virol; 2014 Jun; 86(6):913-7. PubMed ID: 24615989
[TBL] [Abstract][Full Text] [Related]
4. YMDD mutations and genotypes of hepatitis B virus in northern China.
Li D; Gu HX; Zhang SY; Zhong ZH; Zhuang M; Hattori T
Jpn J Infect Dis; 2006 Feb; 59(1):42-5. PubMed ID: 16495633
[TBL] [Abstract][Full Text] [Related]
5. [Identification the relationship between mutation patterns of rtM204I/V in the polymerase gene and genotypes of hepatitis B virus].
Yan L; Xiao L; Wei JF; Sun J; Wang ZH; Hou JL
Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):423-6. PubMed ID: 22053371
[TBL] [Abstract][Full Text] [Related]
6. [Polymerase region mutations and hepatitis B virus genotypes in chronic hepatitis B patients with poor response to lamivudine].
Xu LJ; Pan C; Li QG; Chen RH; Zheng L; Zhang QY; Chen HC
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):180-3. PubMed ID: 20380793
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy changes of short-term lamivudine therapy for chronic hepatitis B with emergence of YMDD mutation].
Deng H; Lv Y; Fu J
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):368-9. PubMed ID: 15225437
[TBL] [Abstract][Full Text] [Related]
8. Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
Selabe SG; Song E; Burnett RJ; Mphahlele MJ
J Med Virol; 2009 Jun; 81(6):996-1001. PubMed ID: 19382250
[TBL] [Abstract][Full Text] [Related]
9. [A real-time PCR assay for the quantification of hepatitis B virus DNA and concurrent detection of YMDD motif mutations].
Ağca H; Sayıner AA; Sengönül A; Simşek I; Akarsu M
Mikrobiyol Bul; 2011 Oct; 45(4):664-76. PubMed ID: 22090297
[TBL] [Abstract][Full Text] [Related]
10. [Types and emergence time of YMDD motif mutation in hepatitis B virus polymerase gene during lamivudine treatment].
Liang WF; Yang DH; Shen YH; Xie YJ; Zhao NF
Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):302-4. PubMed ID: 12773248
[TBL] [Abstract][Full Text] [Related]
11. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
Pan XP; Li LJ; Du WB; Li MW; Cao HC; Sheng JF
J Viral Hepat; 2007 Nov; 14(11):767-74. PubMed ID: 17927612
[TBL] [Abstract][Full Text] [Related]
12. [Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].
Cao XX; Li J; Qiu LM; Luo YW; Chen YH; Ran Y
Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):641-4. PubMed ID: 19785947
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus quantification and detection of YMDD mutants in a single reaction by real-time PCR and annealing curve analysis.
Shih YH; Yeh SH; Chen PJ; Chou WP; Wang HY; Liu CJ; Lu SF; Chen DS
Antivir Ther; 2008; 13(4):469-80. PubMed ID: 18672526
[TBL] [Abstract][Full Text] [Related]
14. A novel accurate ACRS-PCR method with a digestion internal control for identification of wild type and YMDD mutants of hepatitis B virus strains.
Hosseini SY; Sabahi F; Amini-Bavil-Olyaee S; Alavian SM; Merat S
J Virol Methods; 2006 Nov; 137(2):298-303. PubMed ID: 16962669
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine.
Yuen MF; Wong DK; Sablon E; Yuan HJ; Sum SM; Hui CK; Chan AO; Wang BC; Lai CL
Antivir Ther; 2003 Dec; 8(6):531-4. PubMed ID: 14760886
[TBL] [Abstract][Full Text] [Related]
16. [Effects comparison of lamivudine therapy for hepatitis B virus genotypes B and C].
Zhou JL; Wu SP
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):489-90. PubMed ID: 15329211
[TBL] [Abstract][Full Text] [Related]
17. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
Paik YH; Han KH; Hong SP; Lee HW; Lee KS; Kim SO; Shin JE; Ahn SH; Chon CY; Moon YM
Antivir Ther; 2006; 11(4):447-55. PubMed ID: 16856618
[TBL] [Abstract][Full Text] [Related]
18. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.
Akarsu M; Sengonul A; Tankurt E; Sayiner AA; Topalak O; Akpinar H; Abacioglu YH
J Gastroenterol Hepatol; 2006 Dec; 21(12):1783-8. PubMed ID: 17074014
[TBL] [Abstract][Full Text] [Related]
19. [The mutation patterns of HBV P gene and genotyping in patients with lanivudine-resistant chronic hepatitis B].
Tang JL; Zhou JK
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):342-4. PubMed ID: 22338219
[TBL] [Abstract][Full Text] [Related]
20. [Study of gene chips in the detection of YMDD mutations in the region of HBV polymeras].
Zhang XH; Zhang YX; Sun LR; Wen Q; Zhou LQ; Fan GX; Zhang X; Yang DG
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):459-62. PubMed ID: 12887756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
